Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate for anesthesia induction during off-pump coronary artery bypass grafting
ChiCTR2100042310Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and midazolam in coronary arteriosclerosis (4 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Bispectral index, Modified Observer's Assessment of Alertness/Sedation and 8 more. Started Feb 2021; status: recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2100042310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042310.